Revolution Medicines, Inc. (RVMDW) Operating income 2018–2025
Revolution Medicines, Inc. (RVMDW) annual operating income history from SEC filings — each fiscal year as reported.
-$1.2BFY2025 · since FY2018: -$40.3M → -$1.2B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$1.2B | -71.5% |
| FY2024 | -$689.5M | -41.5% |
| FY2023 | -$487.2M | -88.6% |
| FY2022 | -$258.3M | -37.4% |
| FY2021 | -$188.0M | -69.8% |
| FY2020 | -$110.7M | -104.5% |
| FY2019 | -$54.1M | -34.2% |
| FY2018 | -$40.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More RVMDW financial trends
RVMDW RevenueRVMDW Net incomeRVMDW Net marginRVMDW Gross profitRVMDW Gross marginRVMDW Operating marginRVMDW Operating cash flowRVMDW Free cash flowRVMDW Capital expendituresRVMDW Return on equityRVMDW Stock buybacksRVMDW Dividends paidRVMDW Total assetsRVMDW Total liabilitiesRVMDW Shareholders’ equityRVMDW overview →